- Therapy-related myelodysplastic syndrome: a retrospective analysis of data from the Czech Working MDS Group registry2009 | Faculty of Medicine in Hradec Králové
- Therapy-related myelodysplastic syndrome: a retrospective analysis of data from the Czech Working MDS Group registry2009 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Therapy-related myelodysplastic syndrome: a retrospective analysis of data from the Czech Working MDS Group registry2009 | First Faculty of Medicine
- Therapy-related myelodysplastic syndrome : a retrospective analysis of data from the Czech Working MDS Group registry2009 | First Faculty of Medicine
- Experiences with chelation therapy in myelodysplastic syndrome.2009 | Publication without faculty affiliation
- Promising treatment modalities in the therapy of myelodysplastic syndromes2021 | First Faculty of Medicine
- TRANSCRIPTION FACTOR PU.1 IS A TARGET OF 5-AZACITIDINE DURING DIFFERENTIATION THERAPY OF MYELODYSPLASTIC SYNDROMEPublication without faculty affiliation
- Iron overload is a most important adverse effect of long-term transfusion therapy in myelodysplastic syndromePublication without faculty affiliation
- MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia2018 | Publication without faculty affiliation
- Therapy-related myeloid neoplasms in epithelial ovarian cancer patients carrying BRCA1 mutation: Report of two cases2012 | Faculty of Medicine in Hradec Králové
- Incidence, diagnosis and treatment of myelodysplastic syndrome in children in the Czech Republic: results of the prospective study of the EWOG-MDS 1998-20022003 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine